DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Neos Therapeutics Q4 EPS $(0.07) Misses $(0.03) Estimate, Sales $16.832M Miss $20.57M Estimate

Neos Therapeutics (NASDAQ:NEOS) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.03) by 133.33 percent. This is a 69.57 percent increase over losses of $(0.23) per share

Benzinga · 03/13/2020 11:49

Neos Therapeutics (NASDAQ:NEOS) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.03) by 133.33 percent. This is a 69.57 percent increase over losses of $(0.23) per share from the same period last year. The company reported quarterly sales of $16.832 million which missed the analyst consensus estimate of $20.57 million by 18.17 percent. This is a 9.35 percent increase over sales of $15.393 million the same period last year.